The Patent Finder

Orpegen Pharma GmbH

Also on record
Records under this name other than patents Orpegen Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 2 of 2 · Back to Orpegen Pharma GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,835,551Basophil degranulation test
Formerly held
Term ended
Term ended Mar 1, 2019 · USPTO record
Term endedTerm ended Mar 1, 2019USPTO record
US 5,902,733Test system for determining the activity of natural killer cells
Formerly held
Term ended
Term ended no later than May 11, 2019 · Low confidence
Term endedTerm ended no later than May 11, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited